No Detail Found!

COVID-19: Evolving from Myths and Trials to a Potentially Treatable Disease

Author(s)
Afshan Mehvish Naz Institute of Nursing, University of Health Sciences, Lahore, Pakistan.
Samina Kausar Institute of Nursing, University of Health Sciences, Lahore, Pakistan.
Mansoor Ghani Institute of Nursing, University of Health Sciences, Lahore, Pakistan.
Saima Kousar Institute of Nursing, University of Health Sciences, Lahore, Pakistan.
Abstract
Since the COVID-19 outbreak has emerged, every nation and every government are trying its best to combat the disease and develop strategies for better prevention, diagnosis, treatment and management of this lethal virus. Though the mortality rate is far less than any other pandemic the world has experienced, still patients with co-morbid conditions and immune system disorders are at high risk of fatal outcome. There are no approved treatments for COVID-19; thus, people with COVID-19 should be referred to clinical trials. Several agents have been touted as treatments for COVID-19, but at this point, the data are insufficient to inform a recommendation for or against the use of these agents outside of clinical trials; well-conducted randomized trials will be critical in determining how COVID-19 should be treated.
Publication Details
Page(s) 130-136
DOI DOI not available
Published Journal: Biomedica, Volume: 36, Issue: S2, Year: 2020

Request the full text from PASTIC

Keywords
PCR, COVID-19, N95 respirator., Hydroxychloroquine
0

Citations

0

Downloads

64

Views